3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
14
Triple Negative Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Esophageal Squamous Cell Carcinoma
8
Breast Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Small Cell Lung Carcinoma
6
Neoplasms
6
Advanced Solid Tumor
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Recurrence
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Solid Tumor
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Carcinoma, Transitional Cell
3
Turcot syndrome
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
NSCLC
2
Muscle Invasive Bladder Cancer (MIBC)
2
Carcinoma, Squamous Cell
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
Specimen Handling
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Radiosurgery
2
Liver Transplantation
2
Gemcitabine
2
Cisplatin
2
Biopsy
2
tislelizumab
1
sacituzumab govitecan
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
Tegafur
1
S 1 (combination)
1
Pancreatic Hormones
1
Leucovorin
1
Hydroxychloroquine
1
Cyclophosphamide
1
Cholangiopancreatography, Endoscopic Retrograde
1
Capecitabine
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
toripalimab
×
1 year
×
Clear all
No trials found.